Correlation of Microbiome and Metabonomics With IgA Nephropathy
NCT ID: NCT05190848
Last Updated: 2025-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
600 participants
OBSERVATIONAL
2020-05-01
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Observational Study of IgA Nephropathy: Pathological Variants and Clinical Data
NCT01502579
IgA Nephropathy Biomarkers Evaluation Study (INTEREST)
NCT02954419
IgA Nephropathy Registration Initiative of High Quality (INSIGHT)
NCT03001947
Study of the IgA Repertoire During IgA Deposition Nephropathy.
NCT04092491
The Chinese Registry of Prognostic Study of IgA Nephropathy (CRPIGA)
NCT04858724
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Similar samples from IgA nephropathy patients were collected after 2 months and 6 months, respectively, for bacterial community detection and metabolite detection, and the relationship between bacterial community change and metabolite change and disease progression was analyzed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Pregnancy and menstrual period
3. Mental illness and inability to assess follow-up
4. Medically diagnosed intestinal diseases such as irritable bowel syndrome and inflammatory bowel disease
5. Viral hepatitis or other infectious diseases
6. One month before specimen collection, use laxatives including but not limited to polyethylene glycol electrolyte dispersant, enema and other laxatives
16 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Guangdong Provincial People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
XueQing Yu
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xueqing Yu
Role: STUDY_CHAIR
Guangdong Provincial People's Hospital
Xinling Liang
Role: STUDY_DIRECTOR
Guangdong Provincial People's Hospital
Zhiming Ye
Role: STUDY_DIRECTOR
Guangdong Provincial People's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sun Yat-sen Memorial Hospital Sun Yat-sen university
Guangzhou, Guangdong, China
The Third Affiliated Hospital of Southern Medical University
Guangzhou, Guangdong, China
The Third Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China
Guangdong Provincial People's Hospital
Guanzhou, Guangdong, China
The First Affiliated Hospital of Sun Yat-sen University
Guanzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Qiongqiong Yang
Role: primary
Ying Tang
Role: primary
Hui Peng
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GDPH-IgAN-microbiome
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.